Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia

被引：2
|
作者：
Kuprys-Lipinska, Izabela [1 ]
Kolacinska-Flont, Marta [1 ]
Marczak, Jerzy [2 ]
Gorski, Pawel [2 ]
Kurmanowska, Zofia [2 ]
Kuna, Piotr [1 ]
机构：
[1] Med Univ Lodz, Norbert Barlicki Mem Univ Hosp 1, Dept Internal Med Asthma & Allergy, PL-90153 Lodz, Poland
[2] Med Univ Lodz, Norbert Barlicki Mem Univ Hosp 1, Dept Pneumonol & Allergol, PL-90153 Lodz, Poland
来源：
POSTEPY DERMATOLOGII I ALERGOLOGII | 2015年 / 32卷 / 06期
关键词：
ALLERGIC-ASTHMA; INFLAMMATION;
D O I：
10.5114/pdia.2015.48072
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：478 / 479
页数：2
相关论文
共 50 条
  • [21] Relationship between airway eosinophilia and airway hyperresponsiveness in a late asthmatic model of guinea pigs
    Itoh, K
    Takahashi, E
    Mukaiyama, O
    Satoh, Y
    Yamaguchi, Y
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 109 (01) : 86 - 94
  • [22] Long-term effectiveness of omalizumab treatment in Thai severe asthmatic patients: A real-life experience
    Kawamatawong, Theerasuk
    Poachanukoon, Orapan
    Boonsiri, Chalermporn
    Saengasapaviriya, Atik
    Sittipunt, Chanchai
    Chantaphakul, Hiroshi
    Maneechotesuwan, Kittipong
    Ngamchanyaporn, Pintip
    Piyavechviratana, Kunchit
    Yongjaiyut, Praparn
    Khanisap, Apichart
    Juthong, Siwasak
    Rithirak, Warangkana
    Pornsuriyasak, Prapaporn
    Pothirat, Chaicharn
    Boonsawat, Watchara
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2018, 36 (04): : 238 - 243
  • [23] Pulmonary infiltrates with eosinophilia induced by nimesulide in an asthmatic patient
    Perng, DW
    Su, HT
    Tseng, CW
    Lee, YC
    RESPIRATION, 2005, 72 (06) : 651 - 653
  • [24] Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment
    Hermanowicz-Salamon, Joanna
    Nejman-Gryz, Patrycja
    Rubinsztajn, Renata
    Paplinska-Goryca, Magdalena
    Chazan, Ryszarda
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] Cost effectiveness of omalizumab for severe asthma in Colombia
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    Salazar, Andres Felipe Zuluaga
    JOURNAL OF ASTHMA, 2024, 61 (04) : 292 - 299
  • [26] Small airway impairment in severe asthmatic patients
    Contoli, Marco
    Morandi, Luca
    Bellini, Federico
    Soave, Sara
    Forini, Giacomo
    Gnesini, Giulia
    Papi, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [27] A COMPARISON OF ASTHMATIC AND NON-ASTHMATIC SEVERE SMALL AIRWAY DISEASE
    Wilkinson, D. j
    Brice, H. G. T.
    Holmes, L.
    Fowler, S. J.
    Niven, R.
    THORAX, 2013, 68 : A22 - A23
  • [28] Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects
    Mulder, A
    Gauvreau, GM
    Watson, RM
    O'Byrne, PM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (05) : 1562 - 1567
  • [29] Omalizumab for severe food allergy in a large Italian cohort of asthmatic children
    Arasi, S.
    Cafarotti, A.
    Dinardo, G.
    Galletta, F.
    Lo Scalzo, L.
    Tallarico, V.
    Panetta, V.
    Artesani, M. C.
    Dahdah, L.
    Vincenzo, F.
    Riccardi, C.
    Valluzzi, R.
    Fiocchi, A.
    ALLERGY, 2023, 78 : 134 - 135
  • [30] Anti-IgE (Omalizumab) in the treatment of uncontrolled severe asthmatic patients
    Hinojosa, M.
    Huertas, B.
    Gonzalez-Cervera, J.
    Diez-Gomez, M.
    Sanchez-Cano, M.
    Pacheco, A.
    ALLERGY, 2007, 62 : 209 - 209
12345